Mylan’s Bresch has a Good Point about Health Insurance Archives

daniel August 29, 2016 All this gives Mylan a lot of float, Centers for Medicare and Medicaid, epinephrine injector, EpiPen, Is Mylan a Value Investment?, Mylan (NASDAQ: MYL), Mylan CEO Heather Bresch, Mylan is a potential value investment, Mylan’s Bresch, Mylan’s Bresch has a Good Point about Health Insurance

Mylan Unethical Mess or Value Investment

Strangely enough, Bresch actually had a couple of good points about health insurance. She is right to blame the health insurance industry which pays the high costs and finances high pharmaceutical prices.